Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 4(12): e8304, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-20016849

ABSTRACT

BACKGROUND: Hemostasis and thrombosis are regulated by agonist-induced activation of platelet integrin alpha(IIb)beta(3). Integrin activation, in turn is mediated by cellular signaling via protein kinases and protein phosphatases. Although the catalytic subunit of protein phosphatase 1 (PP1c) interacts with alpha(IIb)beta(3), the role of PP1c in platelet reactivity is unclear. METHODOLOGY/PRINCIPAL FINDINGS: Using gamma isoform of PP1c deficient mice (PP1cgamma(-/-)), we show that the platelets have moderately decreased soluble fibrinogen binding and aggregation to low concentrations of thrombin or protease-activated receptor 4 (PAR4)-activating peptide but not to adenosine diphosphate (ADP), collagen or collagen-related peptide (CRP). Thrombin-stimulated PP1cgamma(-/-) platelets showed decreased alpha(IIb)beta(3) activation despite comparable levels of alpha(IIb)beta(3), PAR3, PAR4 expression and normal granule secretion. Functions regulated by outside-in integrin alpha(IIb)beta(3) signaling like adhesion to immobilized fibrinogen and clot retraction were not altered in PP1cgamma(-/-) platelets. Thrombus formation induced by a light/dye injury in the cremaster muscle venules was significantly delayed in PP1cgamma(-/-) mice. Phosphorylation of glycogen synthase kinase (GSK3)beta-serine 9 that promotes platelet function, was reduced in thrombin-stimulated PP1cgamma(-/-) platelets by an AKT independent mechanism. Inhibition of GSK3beta partially abolished the difference in fibrinogen binding between thrombin-stimulated wild type and PP1cgamma(-/-) platelets. CONCLUSIONS/SIGNIFICANCE: These studies illustrate a role for PP1cgamma in maintaining GSK3beta-serine9 phosphorylation downstream of thrombin signaling and promoting thrombus formation via fibrinogen binding and platelet aggregation.


Subject(s)
Blood Platelets/drug effects , Blood Platelets/metabolism , Catalytic Domain , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Protein Phosphatase 1/metabolism , Thrombin/pharmacology , Animals , Blood Platelets/enzymology , Disease Models, Animal , Fibrinogen/metabolism , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Isoenzymes/metabolism , Mice , Phosphoserine/metabolism , Platelet Aggregation/drug effects , Protein Phosphatase 1/deficiency , Proto-Oncogene Proteins c-akt/metabolism , Receptors, Thrombin/metabolism , Secretory Vesicles/drug effects , Secretory Vesicles/metabolism , Signal Transduction/drug effects , Thrombosis/chemically induced , Thrombosis/enzymology , Thrombosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...